Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Langgeng Makmur Industri Tbk. (LMPI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Langgeng Makmur Industri Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Langgeng Makmur Industri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Langgeng Makmur Industri Tbk. trades at Rp158 (market cap 162.37B, 354.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Langgeng Makmur Industri Tbk. and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Langgeng Makmur Industri Tbk. is more actively traded (354.9K versus 324K). Which is the better fit depends on your goals.

LMPIOBAT
Market Cap
162.37B166.01B
Volume
354.9K324K
Lot
3.55K3.24K
Turnover
56.05M77.68M
Average Price
157.92239.75
Value
56.05M77.68M
Indicative Equilibrium Price
158240
Indicative Equilibrium Volume
351

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LMPI
View details
OBAT
View details

About Langgeng Makmur Industri Tbk.

PT. Langgeng Makmur Industri TBk (the Company) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on the Notarial Deed No. 40 dated November 30, 1972 of Kho Boen Tian, S.H., which was amended by Notarial Deed No. 3 dated January 7, 1976 of the same notary concerning the change in the Company name from PT Langgeng Jaya Plastic Industry Ltd., to PT Langgeng Makmur Plastic Industry Ltd. Based on Notarial Deed No. 450 dated June 27, 1997 of Adam Kasdarmadji, S.H., the Company's name has been changed, to PT Langgeng Makmur Industri Tbk.

Read more on LMPI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT